Frequently Asked Questions (FAQ)

Frequently Asked Questions (FAQ)

Background Information on the Share Structure

The shares of BioNTech SE are registered shares (ORD). The conversion into a Societas Europaea (SE) took place on March 8, 2019. The registered shares are not listed on a stock exchange.

In October 2019, BioNTech SE went public on the U.S. Nasdaq Global Select Market. The decision to list on the U.S. stock exchange was made against the background of securing the best possible access to capital for the Company's growth plans which is seen in the highly specialized biotechnology market in the U.S.

As a foreign private issuer, BioNTech has issued American Depositary Shares (ADS). An ADS is an equity share of a non-U.S. company that is held by a U.S. depositary bank. The U.S. depositary bank issues American depositary receipts (ADRs), which are U.S dollar denominated certificates, and evidence of ownership of ADSs. The ADRs represent a certain number of deposited shares in a foreign company and are traded on the U.S. capital market like shares. Each ADS of BioNTech represents one ordinary share.

The American Depositary Shares (ADS) of BioNTech SE are traded on the stock exchange.

ADSs carry certain rights set forth in the Depositary Agreement and are specifically designed to facilitate trading of non-U.S. securities on U.S. exchanges. The FORM F-1 Registration Statement explains the rights in detail.

Structure Sponsored Level 3 ADS
Ratio (ADS:ORD) 1:1
Trading Location Nasdaq; Germany: open market
Ticker Symbol BNTX
ISIN US09075V1026 (WKN: A2PSR2)

For BioNTech’s shareholders, this means that they generally hold ADSs of the Company.

The U.S. depositary bank is generally responsible for forwarding the documents for the Annual General Meeting to the ADS holders. In the case of BioNTech, this is the Bank of New York Mellon . ADS holders are typically informed about the Annual General Meeting by Bank of New York Mellon via the respective banks or brokers. Bank of New York Mellon, also via the ADS holders’ banks or brokers, collects the voting instructions from, and distributes any dividend to, the ADS holders.

How can you as an ADS holder exercise your rights at the Annual General Meeting?

In addition to the distribution of documents by Bank of New York Mellon and the bank/broker in the relevant jurisdiction, all relevant Annual General Meeting documents are available on the Company's website at

The invitation convening the Annual General Meeting has been published in the “Bundesanzeiger”.

BioNTech enables its ADS holders to follow the Annual General Meeting live via video and audio transmission at the following address:

A recording of the speeches from the members of the Supervisory Board and Management Board will be available for four weeks after the Annual General Meeting on the website. The speech and presentation will be available in the archive section on the Investor Relations website.

Please note that ADS holders will not be able to vote directly on Annual General Meeting agenda items during the Annual General Meeting. Bank of New York Mellon, as the U.S. depositary bank, and the bank / broker in the relevant jurisdiction are responsible for sending out the Annual General Meeting documents for the issuance of voting instructions as well as information on applicable deadlines for ADS holders.

In addition, ADS holders have until midnight (CEST) on Monday, May 30, 2022, to submit questions to the Company at the following email address:

No further questions may be asked after the expiry of the aforementioned deadline. The Management Board shall decide how to answer the questions asked from ADS holders at its own discretion. Unless they have expressly objected to being named, it is intended that the parties asking the questions will generally be named when the questions are answered.

BioNTech proposes to distribute a special cash dividend of €2.00 per share pending shareholder approval at our AGM on June 1, 2022. Shareholders holding shares on June 1, 2022, are entitled to receive the dividend pay-out. ADS holders are also entitled to a dividend. The dividend pay-out for ADS holders is handled by Bank of New York Mellon.

Further questions related to ADSs should be directed to BNY Mellon Shareowner Services at:

BNY Mellon Shareowner Services
Telephone: +1 201 680 6825
and toll free in the USA: +1 888 269 2377